Pharmaceutical

BMS secures FDA accelerated approval for Zenbexus in mu...

The combination is intended for patients who have previously received at least o...

Xanadu and University of Alberta to develop quantum alg...

The collaboration aims to develop new quantum algorithms that could accelerate t...

Gulfstream Intelligence launches regulatory intelligenc...

Platform brings regulatory intelligence, labelling, gap assessments, health aut...

Why India’s medicines need integrated authentication, e...

Triggered by recent high profile operations involving counterfeit semaglutide i...

Akeso secures China NMPA authorisation for ivonescimab ...

The decision marks the third NMPA-approved indication for an ivonescimab-contain...

Remepy secures $36m funding for hybrid drug pipeline ex...

The proceeds will also be used to fund Remepy’s lead product Hybridopa’s global ...

BASF introduces Floragenist floral active ingredients f...

BASF’s Personal Care business introduces Floragenist Rose and Floragenist Bloss...

BIRAC showcases biotech and medtech start-ups at Bharat...

BIRAC’s pavilion features start-ups working on medical devices, rehabilitation ...

Back to basics: Metal detection in pharmaceutical manuf...

Stuart Preston explains how metal detection supports contamination control, pro...

Alfasigma signs agreement to acquire Nordic Group

The transaction is structured through a share purchase agreement with SEVER Life...

Mereo BioPharma and Sentynl Therapeutics sign licensing...

The arrangement enables Sentynl to acquire exclusive US commercial rights to alv...

India’s pharma exports rise 6.8% to $8.1 billion in Q1 ...

Pharmexcil data shows growth across formulations, bulk drugs, vaccines and surg...

Amgen to open Science and Innovation Center at Genome V...

The centre is expected to be operational in 2027 and will join Amgen’s global R...

Zydus’ Sentynl enters option and licence deal for alvel...

The agreement covers US commercial and global manufacturing rights to Mereo Bio...

Inside Shilpa Medicare’s growth strategy: Quality, digi...

Dr Vellaian Karuppiah, COO-Management, Shilpa Medicare shares his vision for bu...

BeOne and Revolution Medicines partner for oncology the...

The deal includes joint studies combining BeOne’s cancer pipeline assets with fo...